Pharma & Life Sciences

Clinical Trials in Rare Diseases

The 2026 Rare Trials Summit is a US meeting focused on clinical development, regulatory, operations, evidence, and patient leadership in advancing rare disease therapies. It is intended for professionals involved in rare disease drug development.

The essentials

Event details

Dates
September 2026
Location
InterContinental Boston, United States
Organiser
Rare Trials Summit
Industry
Pharma & Life Sciences

Public discussion

What people are saying

Official hashtag #RareDiseases

Agenda themes

Topics covered

  • Medical & Pharma

On stage

Speakers

  • Annie Kennedy, Chief of Policy, Advocacy, and Patient Engagement, EveryLife Foundation for Rare Diseases
  • Patricia Furlong, Parent Project Muscular Dystrophy
  • Rachel Smith, VP, Rare and Genetic Disease, Parexel
  • Angi Robinson, SVP, Specialty Areas Business Unit (Rare Disease, Pediatrics, CGT), Premier Research

Keep planning

Related events

Spot something wrong on this page? Report a correction and we will fix it.